SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001438533-23-000016
Filing Date
2023-04-13
Accepted
2023-04-13 17:12:47
Documents
22

Document Format Files

Seq Description Document Type Size
1 DEF 14A tvtx-20230413.htm   iXBRL DEF 14A 1583796
6 GRAPHIC tvtx-20230413_g1.jpg GRAPHIC 296047
7 GRAPHIC tvtx-20230413_g2.jpg GRAPHIC 272557
8 GRAPHIC tvtx-20230413_g3.jpg GRAPHIC 275458
9 GRAPHIC tvtx-20230413_g4.jpg GRAPHIC 267420
10 GRAPHIC tvtx-20230413_g5.jpg GRAPHIC 8335
11 GRAPHIC tvtx-20230413_g6.jpg GRAPHIC 10405
12 GRAPHIC tvtx-20230413_g7.jpg GRAPHIC 10716
13 GRAPHIC tvtx-20230413_g8.jpg GRAPHIC 10976
  Complete submission text file 0001438533-23-000016.txt   4980636

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT tvtx-20230413.xsd EX-101.SCH 4016
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT tvtx-20230413_def.xml EX-101.DEF 5136
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT tvtx-20230413_lab.xml EX-101.LAB 7950
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT tvtx-20230413_pre.xml EX-101.PRE 4771
16 EXTRACTED XBRL INSTANCE DOCUMENT tvtx-20230413_htm.xml XML 199107
Mailing Address 3611 VALLEY CENTRE DR SUITE 300 SAN DIEGO CA 92130
Business Address 3611 VALLEY CENTRE DR SUITE 300 SAN DIEGO CA 92130 888-969-7879
Travere Therapeutics, Inc. (Filer) CIK: 0001438533 (see all company filings)

IRS No.: 262383102 | State of Incorp.: CA | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36257 | Film No.: 23819108
SIC: 2834 Pharmaceutical Preparations